Ac8 has solid foundation - I don't see canopy buying out in short term but maybe that is their long term play, they have Metrum health deal to worry about right now, a 1.6b Mkt cap is just astounding. It is not guaranteed that we may not have another CR in the next month, which would draw back the SP probably to .60c, but at this stage everything is moving forward so strong consolidation.
License is much more complicated than I think most people believe as it is controlled by two government bodies that process individual requirements for production and use, these being ODC and TGA, and is further sub-categorized into multiple facets
Research based licensing is a further requirement if the product is being manufactured and used within the same company for those purposes - two separate for human/non-human use
To license for manufacture you need:
ODC licensing:
- a licence and a permit from ODC
- appropriate permission from your state or territory
- if intended for human use (in contrast to laboratory research), you probably also need a GMP licence from the TGA.
An ODC licence allows you to legally cultivate and/or produce cannabis for medicinal or associated research purposes.
You (or your organisation) must have a medicinal cannabis or cannabis research licence (an ODC licence) to obtain the right to lawfully cultivate cannabis for medicinal purposes. Further, once you have a licence, you must obtain a medicinal cannabis or cannabis research permit (an ODC permit) before you can cultivate a crop. The permit sets out the specifics of that crop, such as how much and what type can be grown.
Permit:
A licence does not allow for the cultivation or production of cannabis unless accompanied by an associated permit, which will outline:
Licence preconditions:
- the types of cannabis plants that can be cultivated
- the quantities that can be produced
- the timeframes in which authorised activities can occur
- the next party in the supply chain (specific manufacturer or researcher)
It is a precondition of applying for a licence that you are able to demonstrate that the cultivation and production of the cannabis is for the purposes of either:
Licence requirements:
- supply to the holder of a medicinal cannabis manufacturer licence
- research relating to medicinal cannabis or medicinal cannabis products
There are an extensive set of requirements that must be met to be granted a licence. These include your suitability as the applicant to hold a licence and the suitability of your associates (business, familial, or otherwise) to be associated with a medicinal cannabis business, and the security design and location of any proposed cultivation site.
We require extensive information around these and other issues in support of a licence application. The purpose of such requirements are to allow us to make comprehensive assessments of the suitability of licence applicants and their associates, as well as adequacy of security and other processes around the cultivation of medicinal cannabis.
Information required:
You will be asked to outline the following characteristics of any proposed cultivation or production under your permit:
- types and strains of cannabis - including the concentrations of particular cannabinoids
- size of crop and number of plants
- period of cultivation/production, and
- details of the source material (seeds/cultivars/germplasm etc.)
- details of next party in the supply chain.
- Forums
- ASX - By Stock
- Let's keep it real
Ac8 has solid foundation - I don't see canopy buying out in...
-
- There are more pages in this discussion • 6 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AC8 (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
LPM
LITHIUM PLUS MINERALS LTD.
Simon Kidston, Non--Executive Director
Simon Kidston
Non--Executive Director
SPONSORED BY The Market Online